Valuation: Sirio Pharma Co., Ltd.

Capitalization 5.54B 814M 702M 643M 607M 1.12B 78.77B 1.15B 7.66B 2.98B 37.08B 3.05B 2.99B 129B P/E ratio 2026 *
14.9x
P/E ratio 2027 * 11.3x
Enterprise value 5.54B 814M 702M 643M 607M 1.12B 78.77B 1.15B 7.66B 2.98B 37.08B 3.05B 2.99B 129B EV / Sales 2026 *
1.19x
EV / Sales 2027 * 1.01x
Free-Float
32.29%
Yield 2026 *
2.49%
Yield 2027 * 2.94%
1 day+2.67%
1 week-4.80%
Current month-7.44%
1 month-15.06%
3 months-16.71%
6 months-26.33%
Current year-30.20%
1 week 17.41
Extreme 17.41
18.42
1 month 17.41
Extreme 17.41
21.07
Current year 17.41
Extreme 17.41
26.09
1 year 17.41
Extreme 17.41
28.19
3 years 14.34
Extreme 14.3432
28.19
5 years 12.62
Extreme 12.6213
41.12
10 years 12.05
Extreme 12.0473
49.16
Manager TitleAgeSince
Chief Executive Officer 61 2015-03-31
Director of Finance/CFO 55 2025-07-17
Corporate Officer/Principal 56 2015-03-31
Director TitleAgeSince
Chairman 61 2015-03-31
Director/Board Member 60 2015-03-31
Director/Board Member 56 2015-03-31
Change 5d. change 1-year change 3-years change Capi.($)
+2.67%-4.80%-24.98%-5.85% 793M
-0.35%-3.27%+38.12%+91.70% 14.31B
+0.17%-8.25%-27.80%+165.38% 6.11B
+0.89%-5.49%-10.41%-54.81% 2.48B
+1.96%+3.32% - - 1.56B
+0.68%+1.37%-14.86%-16.30% 1.45B
-2.82%-10.18%+76.66%-8.43% 1.31B
-3.08%-5.27%-86.53%-74.67% 1.08B
-3.01%+0.93%-68.30%-69.66% 1.07B
+0.67%-0.26%-4.82%+7.58% 1.03B
Average -0.22%-1.95%-13.66%+3.88% 3.12B
Weighted average by Cap. -0.16%-3.59%+8.03%+67.53%

Financials

2026 *2027 *
Net sales 4.67B 686M 592M 542M 512M 944M 66.41B 968M 6.46B 2.52B 31.26B 2.57B 2.52B 109B 5.49B 806M 695M 637M 602M 1.11B 78.05B 1.14B 7.59B 2.96B 36.74B 3.03B 2.96B 128B
Net income 375M 55.06M 47.49M 43.5M 41.1M 75.78M 5.33B 77.68M 518M 202M 2.51B 207M 202M 8.76B 494M 72.45M 62.49M 57.24M 54.09M 99.72M 7.01B 102M 682M 266M 3.3B 272M 266M 11.53B
Net Debt - -
Logo Sirio Pharma Co., Ltd.
Sirio Pharma Co Ltd is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company is committed to providing full chain solutions including basic research and product development, manufacturing, packaging, logistics and marketing support for customers in the global nutrition and health food industry. The Company's business scope covers functional food, special dietary food and health food. The Company primarily conducts its businesses in the domestic and overseas markets.
Employees
2,776
Date Price Change Volume
26-05-18 18.05 ¥ +2.67% 1,622,929
26-05-18 17.58 ¥ 0.00% 1,678,766
26-05-15 17.58 ¥ -1.79% 1,722,755
26-05-14 17.90 ¥ -1.59% 1,569,719
26-05-13 18.19 ¥ -0.44% 1,372,692
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18.05CNY
Average target price
28.50CNY
Spread / Average Target
+57.89%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300791 Stock